Top Players Shaping the X-Ray Detectors Market: An In-Depth Analysis

-

The global X-Ray detector market is projected to reach USD 4.0 billion by 2027 from USD 3.1 billion in 2022, at a CAGR of 5.2%. With the rising cases of cancers, cardiovascular diseases, and orthopedic concerns amongst individuals from infants to the geriatric population, everyone globally is suffering from some diseases which should be diagnosed, and X-Ray detectors are the helping aids for medical professionals.

The X-Ray detector market is moderately competitive, with both established companies and upcoming competitors for the same market share. As of 2021, the key player operating in the global X-Ray detector market are Varex Imaging Corporation (US), Canon Inc. (Japan), Agfa-Gevaert NV (Belgium), FUJIFILM Holdings Corporation (Japan)., Thales Group(France), Teledyne Technologies Incorporated (US), Carestream Health, Inc. (US), Konica Minolta, Inc. (Japan), Rayence (US), Vieworks Co., Ltd (South Korea), Hamamatsu Photonics KK (Japan), iRay Technology (China), CareRay Medical Systems Co. (China) and Analogic Corporation (US).

Varex Imaging is headquartered in Utah, United States. In the early decades, the company was known as Varian Medical systems. Varex Imaging Corporation manufactures and sells its medical imaging to cargo screening and border security. The company has its manufacturers globally. The company manufactures X ray detectors, medical OEM X-ray tubes, medical replacement X-ray tubes, NDT X-ray tubes, and different software. The company has adopted inorganic growth strategies such as acquisitions to strengthen its market position. The company has a long-standing customer relationship. Varex gas is good geographic diversification. Varex Imaging Corporation had good investments in its R&D.

Canon (Japan):

Canon is a Japanese MNC headquartered in Tokyo, Japan. It specializes in medical equipment and imaging manufacturers. It was founded in 1937 by Goro Yoshida, Saburo Uchida, and Takeo Maeda.  The medical devices made by canon are computed tomography, medical resonance, Ultrasound, X-ray, and Nuclear medicine. The parent company is Canon Inc. Canon is actively making new deals and acquisitions which is helping the company with the improvement of its brand name. In December 2016, Canon acquired Toshiba Medical Systems Corporation, a key player in the digital X-ray market. In September 2021, Canon acquired 87% shares of Redlen Technologies.

Canon's manufacturing operations are conducted at 29 key plants in Japan and 18 overseas plants in the US, Germany, France, the Netherlands, Taiwan, China, Malaysia, Thailand, Vietnam, and the Philippines, among other locations.

Thales Group(France):

Thales was founded as Thomson-Houston Electric Co. in 1893 in Philadelphia, US. In 2000, the company was renamed Thales, headquartered in Paris, France. The Thales Group operates through four business segments: Aerospace (Aeronautics and Space), Transport, Defense & Security, and Digital Identity and Security. Thales offers X-ray detectors to OEMs through its Trixell division, a joint venture of three companies: Thales Electron Devices, Philips Healthcare, and Siemens Healthcare. Thales Electron Devices has a 51% share in the joint venture. Thales offers X-ray image intensifiers and radiological imaging solutions, while Philips and Siemens offer medical diagnostic and interventional devices. Trixell manufactures X-ray flat-panel detectors for radiological imaging. Trixell also offers detectors for general radiography, fluoroscopy, and cardiovascular applications. The company's business operations are spread across 68 countries in North America, Latin America, Europe, Asia Pacific, Eurasia, the Middle East, and Africa. Some of its key subsidiaries are Thales USA Inc, Thales Suisse SA (Switzerland), Thales Avionics, Inc. (US), Thales Defense & Security, Inc. (US), Thales UK Ltd (UK)., Thales Las France SAS (France), and Thales DMS France SAS (France).

Trixell is the leading company in the radiology sector. It is one the finest producers of X-ray machines. The company is dedicated to innovating, developing, and producing X-ray flat panel digital detectors. It is the face of X-ray detector companies at the international level. The company has a good International Value Chain. Personnel skill development is their focus. The company focuses on its R&D technologies and Innovation. The innovation-centric company invests heavily in R&D to maintain its market share. For example, it has a self-funded R&D for its development

Fujifilm Holdings Corporation (Japan):

Fujifilm Holding Corporation is headquartered in Japan. The use of artificial intelligence and other technology makes them disguised and holds their position firmly in the Xray detectors market.Fujifilm Holding Corporation makes, showcases, and offers support for an expansive range of enterprises, including photographic, clinical imaging and informatics, drug, and other life science ventures. The company has a broad range of xray detectors that are used in cardiology, peripheral intervention, and interventional oncology. Fujifilm Holdings Corporation operates in Latin America, North America, Europe, Asia, the Middle East, and Africa. Fujifilm operates through 310 subsidiaries across the globe

Teledyne Technologies(US)

Teledyne DALSA operates as a subsidiary of Teledyne Technologies Inc. Teledyne DALSA designs, manufactures, and markets electronic imaging components and specialized semiconductors fabrication. This company is based in Canada and has a wide portfolio of Digital Radiography and Flat Panel detectors.

Teledyne Technologies has its manufacturing sites in Canada, the US, and UK. The company has it presence all around the globe with its subsidiaries in Canada, Netherlands,Germany,US, UK, and Sweden.

Related Links

https://www.marketsandmarkets.com/Market-Reports/x-ray-detectors-market-7004984.html

https://www.marketsandmarkets.com/PressReleases/x-ray-detectors.asp

https://www.marketsandmarkets.com/ResearchInsight/x-ray-detectors-market.asp

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more